|
|
Volumn 2, Issue 4, 1996, Pages 381-385
|
|
Tamoxifen: Teaching an old drug new tricks?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1,1,2 TRIPHENYLETHYLENE DERIVATIVE;
ANTIESTROGEN;
CLOMIFENE;
CYTOKINE;
DIETHYLSTILBESTROL;
DROLOXIFENE;
ESTROGEN RECEPTOR;
IDOXIFENE;
LIPOPROTEIN A;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
RALOXIFENE;
TAMOXIFEN;
TAMOXIFEN DERIVATIVE;
TRANSFORMING GROWTH FACTOR BETA;
ATHEROSCLEROSIS;
AUTOIMMUNITY;
BREAST CANCER;
CANCER RISK;
CLINICAL TRIAL;
DRUG SAFETY;
DRUG THERAPY;
ETIOLOGY;
HUMAN;
MULTIPLE SCLEROSIS;
NOTE;
OSTEOPOROSIS;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
RISK BENEFIT ANALYSIS;
SIDE EFFECT;
ARTERIOSCLEROSIS;
AUTOIMMUNE DISEASES;
BREAST NEOPLASMS;
ESTROGEN ANTAGONISTS;
FEMALE;
HUMANS;
OSTEOPOROSIS;
TAMOXIFEN;
|
|
EID: 0029898731
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/nm0496-381 Document Type: Note |
|
Times cited : (120)
|
|
References (0)
|
